GILD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Gilead Sciences Inc

Watchlist Manager

Watchlist

Price: 68.88 EUR 1.09% Market Closed

Market Cap: €85.9B

G	Gilead Sciences Inc MIL:GILD	US
	Citius Pharmaceuticals Inc F:47N	US
	Celldex Therapeutics Inc NASDAQ:CLDX	US
D	Dermapharm Holding SE XBER:DMP	DE
T	Talanx AG XBER:TLX	DE
	Charles River Laboratories International Inc NYSE:CRL	US
I	Integra Lifesciences Holdings Corp XMUN:IL3	US
	Maha Properti Indonesia Tbk PT IDX:MPRO	ID
G	GoDaddy Inc SWB:38D	US

Profitability Summary

Gilead Sciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

78%

Declining Gross Margin

79% > 79%

Exceptional Operating Margin

40%

Strong 3Y Average Operating Margin

38%

Operating Margin is Increasing

39% > 40%

Exceptional Net Margin

31%

Sustainable 3Y Average Net Margin

17%

Net Margin is Increasing

20% > 31%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

31%

Free Cash Flow Margin is Increasing

33% > 34%

Exceptional ROE

43%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

ROIC is Increasing

14% > 21%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.